Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Antoine Ribeil

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|November 24, 2023
Gene-addition/editing therapy in sickle cell diseaseGalia Pollock, Olivier Negre, Jean-Antoine Ribeil
Health Care Transitions|December 23, 2024
Initial outcomes in a sickle cell disease transition clinicKatheryne Madrazo-Aguirre, Jean-Antoine Ribeil, Amy E Sobota
American Journal of Hematology|May 12, 2023
An integrated therapeutic approach to sickle cell disease management beyond infancyJean-Antoine Ribeil, Galia Pollock, Haydar Frangoul, et al.
Stem Cells and Development|October 18, 2016
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of ViewMarina Cavazzana, Jean-Antoine Ribeil, Chantal Lagresle-Peyrou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2009
Fanconi syndrome due to deferasiroxCédric Rafat, Fadi Fakhouri, Jean-Antoine Ribeil, et al.
Thescientificworldjournal|April 23, 2013
Ineffective erythropoiesis in β -thalassemiaJean-Antoine Ribeil, Jean-Benoit Arlet, Michael Dussiot, et al.
Journal of Immunological Methods|February 5, 2008
Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detectionEmanuela Martinuzzi, Matthieu Scotto, Emmanuelle Enée, et al.
Transfusion|September 21, 2007
Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermediaMohamed Bradai, Serge Pissard, Mohand Tayeb Abad, et al.
Journal of Clinical Medicine|January 26, 2020
Primary Hyperparathyroidism in Sickle Cell Disease: An Unknown Complication of the Disease in AdulthoodElsa Denoix, Charlène Bomahou, Lorraine Clavier, et al.
Science Advances|November 19, 2025
Selective AMPKβ1 activation induces fetal hemoglobin in human erythroid cells and sickle cell mice via the noncanonical NRF2 pathwayYannis Hara, Viktor T Lemgart, Samuel Lessard, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|November 24, 2023
Gene-addition/editing therapy in sickle cell diseaseGalia Pollock, Olivier Negre, Jean-Antoine Ribeil
Health Care Transitions|December 23, 2024
Initial outcomes in a sickle cell disease transition clinicKatheryne Madrazo-Aguirre, Jean-Antoine Ribeil, Amy E Sobota
American Journal of Hematology|May 12, 2023
An integrated therapeutic approach to sickle cell disease management beyond infancyJean-Antoine Ribeil, Galia Pollock, Haydar Frangoul, et al.
Stem Cells and Development|October 18, 2016
Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of ViewMarina Cavazzana, Jean-Antoine Ribeil, Chantal Lagresle-Peyrou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2009
Fanconi syndrome due to deferasiroxCédric Rafat, Fadi Fakhouri, Jean-Antoine Ribeil, et al.
Thescientificworldjournal|April 23, 2013
Ineffective erythropoiesis in β -thalassemiaJean-Antoine Ribeil, Jean-Benoit Arlet, Michael Dussiot, et al.
Journal of Immunological Methods|February 5, 2008
Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detectionEmanuela Martinuzzi, Matthieu Scotto, Emmanuelle Enée, et al.
Transfusion|September 21, 2007
Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermediaMohamed Bradai, Serge Pissard, Mohand Tayeb Abad, et al.
Journal of Clinical Medicine|January 26, 2020
Primary Hyperparathyroidism in Sickle Cell Disease: An Unknown Complication of the Disease in AdulthoodElsa Denoix, Charlène Bomahou, Lorraine Clavier, et al.
Science Advances|November 19, 2025
Selective AMPKβ1 activation induces fetal hemoglobin in human erythroid cells and sickle cell mice via the noncanonical NRF2 pathwayYannis Hara, Viktor T Lemgart, Samuel Lessard, et al.
Pageof 5